In this subgroup, it was found that TMB status significantly predicted response to the combination treatment and, while participants with higher TMB exhibited PFS, this did not reach statistical significance.
← all excerpts
Biomarkers for Immunotherapy Efficacy in Advanced Hepatocellular Carcinoma: A Comprehensive Review.
1
—
—